posted on 2023-05-21, 10:26authored byAbu-Raya, B, Migliori, GB, O'Ryan, M, Edwards, K, Torres, A, Alffenaar, JW, Martson, AG, Centis, R, D'Ambrosio, L, Katie FlanaganKatie Flanagan, Hung, I, Lauretani, F, Leung, CC, Leuridan, E, Maertens, K, Maggio, MG, Nadel, S, Hens, N, Niesters, H, Osterhaus, A, Pontali, E, Rossato Silva, D, Omer, S, Spanevello, A, Sverzellati, N, Tan, T, Torres-Torreti, JP, Visca, D, Esposito, S
Coronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 2020, more than 7,000,000 COVID-19 cases have been reported worldwide, and more than 400,000 patients have died, affecting at least 188 countries. While literature on the disease is rapidly accumulating, an integrated, multinational perspective on clinical manifestations, immunological effects, diagnosis, prevention, and treatment of COVID-19 can be of global benefit. We aimed to synthesize the most relevant literature and experiences in different parts of the world through our global consortium of experts to provide a consensus-based document at this early stage of the pandemic.
History
Publication title
Frontiers in Medicine
Volume
7
Pagination
1-20
ISSN
2296-858X
Department/School
Tasmanian School of Medicine
Publisher
Frontiers Media S.A.
Place of publication
Switzerland
Rights statement
Copyright 2020 The Author(s) Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/